Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice

Ionizing radiation (IR) induces p53-dependent apoptosis in radiosensitive tissues, suggesting that p53 is a determinant of radiation syndromes. In fact, p53-deficient mice survive doses of IR that cause lethal hematopoietic syndrome in wild-type animals. Surprisingly, p53 deficiency results in sensitization of mice to higher doses of IR, causing lethal gastro-intestinal (GI) syndrome. While cells in the crypts of p53-wild-type epithelium undergo prolonged growth arrest after irradiation, continuous cell proliferation ongoing in p53-deficient epithelium correlates with accelerated death of damaged cells followed by rapid destruction of villi and accelerated lethality. p21-deficient mice are also characterized by increased sensitivity to GI syndrome-inducing doses of IR. We conclude that p53/p21-mediated growth arrest plays a protective role in the epithelium of small intestine after severe doses of IR. Pharmacological inhibition of p53 by a small molecule that can rescue from lethal hematopoietic syndrome has no effect on the lethality from gastro-intestinal syndrome, presumably because of a temporary and reversible nature of its action.

[1]  I. Roninson,et al.  If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[2]  D. Housman,et al.  p53 status and the efficacy of cancer therapy in vivo. , 1994, Science.

[3]  A. Gudkov,et al.  Different impact of p53 and p21 on the radiation response of mouse tissues , 2000, Oncogene.

[4]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[5]  A. Gudkov,et al.  The role of p53 in determining sensitivity to radiotherapy , 2003, Nature Reviews Cancer.

[6]  C. Potten,et al.  The intestinal epithelial stem cell: the mucosal governor , 1997, International journal of experimental pathology.

[7]  C. Culmsee,et al.  Novel p53 inactivators with neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives. , 2002, Journal of medicinal chemistry.

[8]  C. Potten,et al.  Characterization of radiation-induced apoptosis in the small intestine and its biological implications. , 1994, International journal of radiation biology.

[9]  C. Potten,et al.  Apoptosis in small intestinal epithelia from p53-null mice: evidence for a delayed, p53-indepdendent G2/M-associated cell death after γ-irradiation , 1997, Oncogene.

[10]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[11]  Z. Somosy,et al.  Morphological aspects of ionizing radiation response of small intestine. , 2002, Micron.

[12]  A. Gudkov,et al.  Could p53 be a target for therapeutic suppression? , 1998, Seminars in cancer biology.

[13]  Ericka Stricklin-Parker,et al.  Ann , 2005 .

[14]  S. Tsuchida,et al.  Transcriptional Activation of the MUC2 Gene by p53* , 2002, The Journal of Biological Chemistry.